Related references
Note: Only part of the references are listed.Tickets to the brain: Role of CCR2 and CX3CR1 in myeloid cell entry in the CNS
Marco Prinz et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Zeroing in on LRRK2-linked pathogenic mechanisms in Parkinson's disease
Saskia Biskup et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
Peripheral cytokines profile in Parkinson's disease
M. Reale et al.
BRAIN BEHAVIOR AND IMMUNITY (2009)
Chemokines and Chemokine Receptors: Standing at the Crossroads of Immunobiology and Neurobiology
Richard M. Ransohoff
IMMUNITY (2009)
Differential neutrophil infiltration contributes to regional differences in brain inflammation in the substantia nigra pars compacta and cortex
Kyung-Ae Ji et al.
GLIA (2008)
Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFα, and INFγ concentrations are elevated in patients with atypical and idiopathic parkinsonism
Bogdan Brodacki et al.
NEUROSCIENCE LETTERS (2008)
Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions
Alexander Mildner et al.
NATURE NEUROSCIENCE (2007)
TNF-α knockout and minocycline treatment attenuates blood-brain barrier leakage in MPTP-treated mice
Chaohui Zhao et al.
NEUROBIOLOGY OF DISEASE (2007)
Chemokines in the MPTP model of Parkinson's disease: Absence of CCL2 and its receptor CCR2 does not protect against striatal neurodegeneration
Yogeshwar V. Kalkonde et al.
BRAIN RESEARCH (2007)
Blood-brain barrier pathology in Alzheimer's and Parkinson's disease: Implications for drug therapy
Brinda S. Desai et al.
CELL TRANSPLANTATION (2007)
Minocycline reduces the lipopolysaccharide-induced inflammatory reaction, peroxynitrite-mediated nitration of proteins, disruption of the blood-brain barrier, and damage in the nigral dopaminergic system
M Tomás-Camardiel et al.
NEUROBIOLOGY OF DISEASE (2004)
Share Paper
